Silicon based electronics are expected to run out of steam shortly, and the search is on for a suitable replacement. There are many areas to look at when considering the future of electronics -- better architecture, better materials, better algorithms, better metrology, novel computational paradigms, bio-inspired computing etc. Our vision is to use theory, modeling, and predictive computational tools to provide a unified understanding that would guide strategic research in these disparate areas towards a common goal.
Boris Gelmont's present research area includes theoretical aspects of electronic materials and devices, theory of novel semiconductor devices (resonant tunneling diodes, quantum cascade lasers), modeling of devices (field effect transistors,Schottky diodes), transport and optical properties of semiconductors.
Our research program is concerned with the synthesis, properties and applications of metal complexes with polymeric ligands. Along with fundamental studies in polymer synthesis and properties, we are also exploring uses for these materials in medicine, biotechnology, and photonics. Of particular interest are biocompatible and degradable polymers for drug delivery and other biomedical materials, optical imaging and oxygen sensing, and sustainable design.
Research and teaching interests include the processing, modeling, and behavior of nanofunctional and electronic materials and their novel contributions to the electronic and biomedical communities.
The sequencing of the human genome promises to provide numerous new proteins as drug targets and therapeutic agents. We are investigating several obstacles to the efficient commercialization of these delicate molecules. In addition, we are exploring protein misfolding relating to human disease.
My research strives to develop appropriate technology-based solutions to address important issues that challenge HIV-infected patients both in resource-poor settings and the United States.
We are interested in developing new or improved catalytic materials by studying how the structure of a catalyst affects its performance in a chemical reaction.
As a clinician scientist, Dr. Cui and his research team will create an optimal deliverable bone graft substitute to enhance bone repair and to provide novel treatement for osteonecrosis and osteolysis.
We explore the molecular mechanisms of the pathogenesis of the obligate human pathogen Neisseria gonorrhoeae. The insights gleaned from these studies will facilitate our understanding of how the innate immune system defends against infection, how pathogens exploit mucosal defenses to aid in colonization and transmission, and how the structure-function relationship of pathogen-associated surface proteins modulates the infection process.